{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T18:54:06Z","timestamp":1735584846473},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Big Data"],"DOI":"10.3389\/fdata.2020.00024","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T13:45:03Z","timestamp":1597239903000},"update-policy":"http:\/\/dx.doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":47,"title":["Statistical Disease Progression Modeling in Alzheimer Disease"],"prefix":"10.3389","volume":"3","author":[{"given":"Lars Lau","family":"Raket","sequence":"first","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2020,8,12]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-4612-1694-0_15","article-title":"\u201cInformation theory and an extension of the maximum likelihood principle,\u201d","volume-title":"Selected Papers of Hirotugu Aakaike","author":"Akaike","year":"1998"},{"key":"B2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jalz.2018.02.001","article-title":"2018 Alzheimer's disease facts and figures","volume":"14","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1017\/S1355617706060206","article-title":"The effect of education and occupational complexity on rate of cognitive decline in Alzheimer's patients","volume":"12","author":"Andel","year":"2006","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1016\/S0140-6736(17)32399-1","article-title":"Why do so many clinical trials of therapies for Alzheimer's disease fail?","volume":"390","author":"Anderson","year":"2017","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.trci.2019.04.001","article-title":"Enrichment factors for clinical trials in mild-to-moderate Alzheimer's disease","volume":"5","author":"Ballard","year":"2019","journal-title":"Alzheimers Dement. Transl. Res. Clin. Intervent."},{"key":"B6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jalz.2011.05.2409","article-title":"Gaining precision on the Alzheimer's disease assessment scale-cognitive: a comparison of item response theory-based scores and total scores","volume":"8","author":"Balsis","year":"2012","journal-title":"Alzheimers Dement."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/alzrt59","article-title":"Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease","volume":"3","author":"Bateman","year":"2011","journal-title":"Alzheimers Res. Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jalz.2016.07.005","article-title":"The DIAN-TU next generation Alzheimer's prevention trial: adaptive design and disease progression model","volume":"13","author":"Bateman","year":"2017","journal-title":"Alzheimers Dement"},{"key":"B9","doi-asserted-by":"publisher","first-page":"CD005593","DOI":"10.1002\/14651858.CD005593","article-title":"Cholinesterase inhibitors for Alzheimer's disease","volume":"1","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jalz.2015.09.009","article-title":"Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of \u03b2-amyloid (1\u201342) in human cerebrospinal fluid","volume":"12","author":"Bittner","year":"2016","journal-title":"Alzheimers Dement."},{"key":"B11","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13195-018-0443-2","article-title":"Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer's disease clinical program","volume":"10","author":"Cummings","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1038\/psp.2013.54","article-title":"Modeling Alzheimer's disease progression using disease onset time and disease trajectory concepts applied to CDR-SoB scores from ADNI","volume":"2","author":"Delor","year":"2013","journal-title":"CPT Pharmacometr. Syst. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jalz.2013.10.003","article-title":"Estimating long-term multivariate progression from short-term data","volume":"10","author":"Donohue","year":"2014","journal-title":"Alzheimers Dement."},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.4324\/9781410605269","volume-title":"Item Response Theory.","author":"Embretson","year":"2013"},{"key":"B15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41582-018-0032-9","article-title":"Sex differences in Alzheimer disease\u2014the gateway to precision medicine","volume":"14","author":"Ferretti","year":"2018","journal-title":"Nat Rev Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","article-title":"FreeSurfer","volume":"62","author":"Fischl","year":"2012","journal-title":"Neuroimage"},{"key":"B17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/alzrt181","article-title":"Dementia in the oldest old: a multi-factorial and growing public health issue","volume":"5","author":"Gardner","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jalz.2010.12.012","article-title":"Modeling Alzheimer's disease progression using the disease system analysis approach","volume":"8","author":"Gomeni","year":"2012","journal-title":"Alzheimers Dement."},{"key":"B19","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"Br. J. Psychiatr."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1212\/WNL.0000000000007831","article-title":"Determining clinically meaningful decline in preclinical Alzheimer disease","volume":"93","author":"Insel","year":"2019","journal-title":"Neurology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jalz.2010.03.018","article-title":"Disease progression model for cognitive deterioration from Alzheimer's disease neuroimaging initiative database","volume":"7","author":"Ito","year":"2011","journal-title":"Alzheimers Dement."},{"key":"B22","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.neuroimage.2012.07.059","article-title":"A computational neurodegenerative disease progression score: method and results with the Alzheimer's disease neuroimaging initiative cohort","volume":"63","author":"Jedynak","year":"2012","journal-title":"Neuroimage"},{"key":"B24","doi-asserted-by":"publisher","first-page":"S178","DOI":"10.1016\/j.neurobiolaging.2014.03.043","article-title":"A computational method for computing an Alzheimer's disease progression score; experiments and validation with the ADNI data set","volume":"36","author":"Jedynak","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e184080","DOI":"10.1001\/jamanetworkopen.2018.4080","article-title":"Association of concomitant use of cholinesterase inhibitors or memantine with cognitive decline in alzheimer clinical trials: a meta-analysis","volume":"1","author":"Kennedy","year":"2018","journal-title":"JAMA Netw Open"},{"key":"B26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3389\/fneur.2018.00235","article-title":"Spatiotemporal propagation of the cortical atrophy: population and individual patterns","volume":"9","author":"Koval","year":"2018","journal-title":"Front. Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2967\/jnumed.114.148981","article-title":"Measurement of longitudinal \u03b2-amyloid change with 18F-florbetapir PET and standardized uptake value ratios","volume":"56","author":"Landau","year":"2015","journal-title":"J. Nucl. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.neurobiolaging.2009.07.002","article-title":"Alzheimer's disease neuroimaging initiative. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI","volume":"32","author":"Landau","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"B29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10928-015-9459-4","article-title":"What do we mean by identifiability in mixed effects models?","volume":"43","author":"Lavielle","year":"2016","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"B30","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.dadm.2018.07.008","article-title":"Alzheimer's disease neuroimaging initiative. Bayesian latent time joint mixed-effects model of progression in the Alzheimer's disease neuroimaging initiative","volume":"10","author":"Li","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B31","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2307\/2532087","article-title":"Nonlinear mixed effects models for repeated measures data","author":"Lindstrom","year":"1990","journal-title":"Biometrics"},{"key":"B32","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/978-3-030-20351-1_42","article-title":"Riemannian geometry learning for disease progression modelling","volume-title":"International Conference on Information Processing in Medical Imaging","author":"Louis","year":"2019"},{"key":"B33","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1097\/00002093-199700112-00003","article-title":"Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's disease assessment scale that broaden its scope","volume":"11","author":"Mohs","year":"1997","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1007\/s00415-009-5116-4","article-title":"Predictors of progression of cognitive decline in Alzheimer's disease: the role of vascular and sociodemographic factors","volume":"256","author":"Musicco","year":"2009","journal-title":"J. Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1111\/rssc.12276","article-title":"Simultaneous inference for misaligned multivariate functional data","volume":"67","author":"Olsen","year":"2018","journal-title":"J. R. Stat. Soc. C"},{"key":"B37","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00401-018-1920-1","article-title":"Sex differences in Alzheimer's disease and common neuropathologies of aging","volume":"136","author":"Oveisgharan","year":"2018","journal-title":"Acta Neuropathol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1093\/brain\/awy050","article-title":"Data-driven models of dominantly-inherited Alzheimer's disease progression","volume":"141","author":"Oxtoby","year":"2018","journal-title":"Brain"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1212\/WNL.0000000000001991","article-title":"Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease","volume":"85","author":"Palmqvist","year":"2015","journal-title":"Neurology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/geronj\/37.3.323","article-title":"Measurement of functional activities in older adults in the community","volume":"37","author":"Pfeffer","year":"1982","journal-title":"J. Gerontol."},{"key":"B41","author":"Pinheiro","year":"2019","journal-title":"nlme: Linear and Nonlinear Mixed Effects Models"},{"key":"B42","author":"Pinheiro","year":"2006","journal-title":"Mixed-Effects Models in S and S-PLUS."},{"key":"B43","unstructured":"R: A Language and Environment for Statistical Computing. Vienna2020"},{"key":"B44","unstructured":"RaketL. L.\n progmod2020"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.patrec.2013.10.018","article-title":"A nonlinear mixed-effects model for simultaneous smoothing and registration of functional data","volume":"38","author":"Raket","year":"2014","journal-title":"Pattern Recogn. Lett."},{"key":"B46","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1214\/ss\/1177012761","article-title":"Monotone regression splines in action","volume":"3","author":"Ramsay","year":"1988","journal-title":"Stat. Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1006\/brcg.1996.0038","article-title":"Predicting rate of cognitive decline in probable Alzheimer's disease","volume":"31","author":"Rasmusson","year":"1996","journal-title":"Brain Cogn."},{"key":"B48","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1212\/WNL.0000000000000596","article-title":"Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis","volume":"83","author":"Ryman","year":"2014","journal-title":"Neurology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0091270011405497","article-title":"An improved model for disease progression in patients from the Alzheimer's disease neuroimaging initiative","volume":"52","author":"Samtani","year":"2012","journal-title":"J. Clin. Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1136\/jnnp.2005.072306","article-title":"Education and rates of cognitive decline in incident Alzheimer's disease","volume":"77","author":"Scarmeas","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"B51","unstructured":"A Bayesian mixed-effects model to learn trajectories of changes from repeated manifold-valued observations48404872\n SchirattiJ.-B.\n AllassonniereS.\n ColliotO.\n DurrlemanS.\n J. Mach. Learn. Res.182017"},{"key":"B52","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1017\/S1041610211002389","article-title":"Could cholinesterase inhibitors be harmful over the long term?","volume":"24","author":"Schneider","year":"2012","journal-title":"Int Psychogeriatr."},{"key":"B53","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1214\/aos\/1176344136","article-title":"Estimating the dimension of a model","volume":"6","author":"Schwarz","year":"1978","journal-title":"Ann. Stat."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3233\/JAD-181047","article-title":"Rate of cognitive decline in Alzheimer's disease stratified by age","volume":"69","author":"Stanley","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","article-title":"Cognitive reserve in ageing and Alzheimer's disease","volume":"11","author":"Stern","year":"2012","journal-title":"Lancet Neurol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"M49","DOI":"10.1093\/gerona\/50A.1.M49","article-title":"Cognitive decline in Alzheimer's disease: a longitudinal investigation of risk factors for accelerated decline","volume":"50","author":"Teri","year":"1995","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jalz.2016.01.002","article-title":"Longitudinal decline in mild-to-moderate Alzheimer's disease: analyses of placebo data from clinical trials","volume":"12","author":"Thomas","year":"2016","journal-title":"Alzheimers Dement."},{"key":"B58","doi-asserted-by":"publisher","first-page":"354","DOI":"10.2174\/156720511795745320","article-title":"Cognitive reserve in aging","volume":"8","author":"Tucker","year":"2011","journal-title":"Curr. Alzheimer Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jalz.2018.12.008","article-title":"Dominantly inherited Alzheimer network. Staging biomarkers in preclinical autosomal dominant Alzheimer's disease by estimated years to symptom onset","volume":"15","author":"Wang","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1212\/01.WNL.0000140488.65299.53","article-title":"Education and the course of cognitive decline in Alzheimer disease","volume":"63","author":"Wilson","year":"2004","journal-title":"Neurology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3233\/JAD-2011-110551","article-title":"Quantifying the pathophysiological timeline of Alzheimer's disease","volume":"26","author":"Yang","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1093\/brain\/awu176","article-title":"A data-driven model of biomarker changes in sporadic Alzheimer's disease","volume":"137","author":"Young","year":"2014","journal-title":"Brain"}],"container-title":["Frontiers in Big Data"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fdata.2020.00024\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T13:45:12Z","timestamp":1597239912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fdata.2020.00024\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,12]]},"references-count":62,"alternative-id":["10.3389\/fdata.2020.00024"],"URL":"https:\/\/doi.org\/10.3389\/fdata.2020.00024","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2019.12.13.19014860","asserted-by":"object"}]},"ISSN":["2624-909X"],"issn-type":[{"value":"2624-909X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,12]]}}}